Multimodal assessment of exceptional responders refines subtyping-directed precision treatment in HR+/HER2- breast cancer. (jci.org)

Authors: Xiao Y … Shao ZM Journal: Journal of Clinical Investigation Published: 2026-10-15 DOI: https://doi.org/10.1172/JCI202305